LVHN: LVHN, UPHS Cancer Clinical Trials

Two immunotherapry drugs for skin cancer, the most common of all cancers, have been the subject of a recent clinical trial. Nivolumab and Ipilimumab, made by Bristol Myers Squibb, showed promise to fight melanoma when administered individually. The trial, to discover if there might be some clinical benefit if given sequentially, is being run by locally the University of Pennsylvania Health System and Lehigh Valley Health Network.

Suresh Nair, M.D., has been working with cancer patients and clinical trials for the last 24 years and is the senior medical director of academic oncology programs at LVHN. For him, getting clinical trials like this one at a community hospital is the culmination of a lifetime of work.

He said that the secret to getting high-level, highly sought after clinical trials lies in the strength of the team and the willingness of LVHN to put the necessary resources and time into creating a great cancer program.

SLUHN: Veny to speak May 29

Mike Veny, a speaker and professional drummer, will speak on the stigma of mental illness from 7 to 8:30 p.m. May 29 at St. Luke's Doctor's Pavilion St. Luke's University Hospital-Bethlehem, 701 Ostrum St. He will shares his own experiences struggling with mental illness and offers special insight into transforming his personal challenges into strengths. RSVP to 484-526-4104 by May 28.